{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:07:19Z","timestamp":1791295639181,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"University of Naples \u201cFederico II\u201d, Italy"},{"name":"French National Institute of Agronomic Research (INRA)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.bbadis.2012.09.005","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T20:20:51Z","timestamp":1348604451000},"page":"20-28","source":"Crossref","is-referenced-by-count":39,"title":["Binding of methylene blue to a surface cleft inhibits the oligomerization and fibrillization of prion protein"],"prefix":"10.1016","volume":"1832","author":[{"given":"Paola","family":"Cavaliere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Torrent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Prigent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Granata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Pauwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Human","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Zagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2012.09.005_bb0005","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/00019052-199312000-00008","article-title":"Alzheimer's disease and Creutzfeldt\u2013Jakob disease: overlap of pathogenic mechanisms","volume":"6","author":"DeArmond","year":"1993","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0010","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJM200105173442006","article-title":"Shattuck lecture\u2013neurodegenerative diseases and prions","volume":"344","author":"Prusiner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0015","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1126\/science.1087348","article-title":"Games played by rogue proteins in prion disorders and Alzheimer's disease","volume":"302","author":"Aguzzi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2012.09.005_bb0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.emboj.7601930","article-title":"The two faces of protein misfolding: gain- and loss-offunction in neurodegenerative diseases","volume":"27","author":"Winklhofer","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0025","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0035","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2174\/156720508786898497","article-title":"Prion protein oligomerization","volume":"5","author":"Rezaei","year":"2008","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0959-440X(98)80016-X","article-title":"The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways","volume":"8","author":"Kelly","year":"1998","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0045","doi-asserted-by":"crossref","first-page":"2325.e7","DOI":"10.1016\/j.neurobiolaging.2010.12.012","article-title":"Lest we forget you\u2014methylene blue \u2026","volume":"32","author":"Schirmer","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2012.09.005_bb0050","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.bcp.2009.04.034","article-title":"Methylene blue and Alzheimer's disease","volume":"78","author":"Oz","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/10520296809115068","article-title":"Supravital staining of mammalian brain with intraarterial methylene blue followed by pressurized oxygen","volume":"43","author":"O'Leary","year":"1968","journal-title":"Stain Technol."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s002280000124","article-title":"Pharmacokinetics and organ distribution of intravenous and oral methylene blue","volume":"56","author":"Peter","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0065","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1021\/bi700411k","article-title":"Methylene blue inhibits amyloid A\u03b2 oligomerization by promoting fibrillization","volume":"46","author":"Necula","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2012.09.005_bb0070","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M408714200","article-title":"Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins","volume":"280","author":"Taniguchi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0075","doi-asserted-by":"crossref","first-page":"15714","DOI":"10.1074\/jbc.M109.098806","article-title":"Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation","volume":"285","author":"Wang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0080","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.febslet.2009.06.042","article-title":"Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models","volume":"14","author":"Yamashita","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0085","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.1073\/pnas.161274798","article-title":"Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease","volume":"98","author":"Korth","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1423-0410.2010.01456.x","article-title":"Characteristics of prion-filtered red cells suspended in pathogen-inactivated plasma (MB treated or solvent-detergent treated) for neonatal exchange transfusion","volume":"101","author":"Hornsey","year":"2010","journal-title":"Vox Sang."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0095","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1529\/biophysj.107.108613","article-title":"Structural and hydration properties of the partially unfolded states of the prion protein","volume":"93","author":"De Simone","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0100","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1046\/j.1432-1033.2000.01347.x","article-title":"High yield purification and physico-chemical properties of full-length recombinant allelic variants of sheep prion protein linked to scrapie susceptibility","volume":"267","author":"Rezaei","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0006-3495(92)81899-4","article-title":"Theoretical analysis of Lumry\u2013Eyring models in differential scanning calorimetry","volume":"61","author":"Sanchez-Ruiz","year":"1992","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.09-153924","article-title":"The oligomerization properties of prion protein are restricted to the H2H3 domain","volume":"24","author":"Chakroun","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0115","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1073\/pnas.0607745104","article-title":"Diversity in prion protein oligomerization pathways results from domain expansion as revealed by hydrogen\/deuterium exchange and disulfide linkage","volume":"104","author":"Eghiaian","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4161\/pri.5.2.16383","article-title":"PrP assemblies: spotting the responsible regions in prion propagation","volume":"5","author":"Prigent","year":"2011","journal-title":"Prion"},{"key":"10.1016\/j.bbadis.2012.09.005_bb0125","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0022-2836(02)00856-2","article-title":"Amyloidogenic unfolding intermediates differentiate sheep prion protein variants","volume":"322","author":"Rezaei","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jmb.2005.01.043","article-title":"Sequential generation of two structurally distinct ovine prion protein soluble oligomers displaying different biochemical reactivities","volume":"347","author":"Rezaei","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0135","doi-asserted-by":"crossref","first-page":"10288","DOI":"10.1128\/JVI.77.19.10288-10294.2003","article-title":"New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products","volume":"77","author":"Kocisko","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0140","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1073\/pnas.97.11.6073","article-title":"Mimicking dominant negative inhibition of prion replication through structure-based drug design","volume":"97","author":"Perrier","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0145","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nchembio.246","article-title":"A synergistic small-molecule combination directly eradicates diverse prion strain structures","volume":"5","author":"Roberts","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0150","first-page":"3209","article-title":"Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways","volume":"286","author":"Ladiwala","year":"2011","journal-title":"J. Biol. Mol."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0155","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","article-title":"Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines","volume":"93","author":"Wischik","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0160","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1471-4159.1992.tb09437.x","article-title":"Potent inhibition of scrapie-associated PrP accumulation by congo red","volume":"59","author":"Caughey","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0165","doi-asserted-by":"crossref","first-page":"11921","DOI":"10.1073\/pnas.0702671104","article-title":"Hot spots in prion protein for pathogenic conversion","volume":"104","author":"Kuwata","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0170","doi-asserted-by":"crossref","first-page":"17610","DOI":"10.1073\/pnas.1009062107","article-title":"Pharmacological chaperone for the structured domain of human prion protein","volume":"107","author":"Nicoll","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0175","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1074\/jbc.273.6.3484","article-title":"The anti-prion activity of Congo red. Putative mechanism","volume":"273","author":"Caspi","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2012.09.005_bb0180","doi-asserted-by":"crossref","first-page":"e20244","DOI":"10.1371\/journal.pone.0020244","article-title":"Molecular structure of amyloid fibrils controls the relationship between fibrillar size and toxicity","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2012.09.005_bb0185","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","article-title":"Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution","volume":"81","author":"Stefani","year":"2003","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.bbadis.2012.09.005_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/science.1100195","article-title":"Synthetic mammalian prions","volume":"305","author":"Legname","year":"2004","journal-title":"Science"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443912002141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443912002141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T14:52:52Z","timestamp":1542725572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443912002141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0925443912002141"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2012.09.005","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}